• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干眼疾病中的细胞应激——恶性循环的关键枢纽

Cellular Stress in Dry Eye Disease-Key Hub of the Vicious Circle.

作者信息

van Setten Gysbert-Botho

机构信息

St. Eriks Eye Hospital, 17164 Solna, Sweden.

Department of Clinical Neuroscience, Division of Eye and Vision, Lab of DOHF and Wound Healing, Karolinska Institutet, Eugeniavägen 12/Level 6, 17104 Solna, Sweden.

出版信息

Biology (Basel). 2024 Aug 28;13(9):669. doi: 10.3390/biology13090669.

DOI:10.3390/biology13090669
PMID:39336096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11428556/
Abstract

Disturbance or insufficiency of the tear film challenges the regulatory systems of the ocular surfaces. The reaction of the surfaces includes temporary mechanisms engaged in the preservation of homeostasis. However, strong or persisting challenges can lead to the potential exhaustion of the coping capacity. This again activates the vicious circle with chronic inflammation and autocatalytic deterioration. Hence, the factors challenging the homeostasis should be addressed in time. Amongst them are a varying osmolarity, constant presence of small lesions at the epithelium, acidification, attrition with mechanical irritation, and onset of pain and discomfort. Each of them and, especially when occurring simultaneously, impose stress on the coping mechanisms and lead to a stress response. Many stressors can culminate, leading to an exhaustion of the coping capacity, outrunning normal resilience. Reaching the limits of stress tolerance leads to the manifestation of a lubrication deficiency as the disease we refer to as dry eye disease (DED). To postpone its manifestation, the avoidance or amelioration of stress factors is one key option. In DED, this is the target of lubrication therapy, substituting the missing tear film or its components. The latter options include the management of secondary sequelae such as the inflammation and activation of reparative cascades. Preventive measures include the enhancement in resilience, recovery velocity, and recovery potential. The capacity to handle the external load factors is the key issue. The aim is to guard homeostasis and to prevent intercellular stress responses from being launched, triggering and invigorating the vicious circle. Considering the dilemma of the surface to have to cope with increased time of exposure to stress, with simultaneously decreasing time for cellular recovery, it illustrates the importance of the vicious circle as a hub for ocular surface stress. The resulting imbalance triggers a continuous deterioration of the ocular surface condition. After an initial phase of the reaction and adaption of the ocular surface to the surrounding challenges, the normal coping capacity will be exhausted. This is the time when the integrated stress response (ISR), a protector for cellular survival, will inevitably be activated, and cellular changes such as altered translation and ribosome pausing are initiated. Once activated, this will slow down any recovery, in a phase where apoptosis is imminent. Premature senescence of cells may also occur. The process of prematurization due to permanent stress exposures contributes to the risk for constant deterioration. The illustrated flow of events in the development of DED outlines that the ability to cope, and to recover, has limited resources in the cells at the ocular surface. The reduction in and amelioration of stress hence should be one of the key targets of therapy and begin early. Here, lubrication optimization as well as causal treatment such as the correction of anatomical anomalies (leading to anatomical dry eye) should be a prime intent of any therapy. The features of cellular stress as a key hub for the vicious circle will be outlined and discussed.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c57/11428556/84075af842b3/biology-13-00669-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c57/11428556/a7da4a36a1a7/biology-13-00669-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c57/11428556/10bf87dd56d4/biology-13-00669-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c57/11428556/4279ba1cc1cc/biology-13-00669-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c57/11428556/2a479a989efa/biology-13-00669-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c57/11428556/84075af842b3/biology-13-00669-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c57/11428556/a7da4a36a1a7/biology-13-00669-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c57/11428556/10bf87dd56d4/biology-13-00669-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c57/11428556/4279ba1cc1cc/biology-13-00669-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c57/11428556/2a479a989efa/biology-13-00669-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c57/11428556/84075af842b3/biology-13-00669-g005.jpg
摘要

泪膜的紊乱或不足会对眼表的调节系统构成挑战。眼表的反应包括参与维持内环境稳定的临时机制。然而,强烈或持续的挑战可能导致应对能力的潜在耗尽。这又会激活慢性炎症和自身催化恶化的恶性循环。因此,应及时应对挑战内环境稳定的因素。其中包括渗透压的变化、上皮细胞持续存在小损伤、酸化、机械刺激引起的磨损以及疼痛和不适的发作。它们中的每一个,尤其是同时出现时,都会给应对机制带来压力并导致应激反应。许多应激源可能累积起来,导致应对能力耗尽,超出正常恢复能力。达到应激耐受极限会导致润滑不足的表现,即我们所说的干眼病(DED)。为了推迟其表现,避免或改善应激因素是一个关键选择。在干眼病中,这是润滑治疗的目标,即替代缺失的泪膜或其成分。后一种选择包括处理继发性后遗症,如炎症和修复级联反应的激活。预防措施包括提高恢复能力、恢复速度和恢复潜力。应对外部负荷因素的能力是关键问题。目的是保护内环境稳定,防止引发和加剧恶性循环的细胞内应激反应。考虑到眼表面临的困境,即暴露于应激的时间增加,而细胞恢复时间同时减少,这说明了恶性循环作为眼表应激中心的重要性。由此产生的失衡会引发眼表状况的持续恶化。在眼表对周围挑战的反应和适应的初始阶段之后,正常的应对能力将被耗尽。此时,作为细胞存活保护者的综合应激反应(ISR)将不可避免地被激活,并引发细胞变化,如翻译改变和核糖体暂停。一旦被激活,这将在细胞凋亡迫在眉睫的阶段减缓任何恢复。细胞也可能过早衰老。由于长期应激暴露导致的过早成熟过程会增加持续恶化的风险。干眼病发展过程中所示的事件流程表明,眼表细胞应对和恢复的能力资源有限。因此,减轻和改善应激应是治疗的关键目标之一,并应尽早开始。在此,润滑优化以及因果治疗,如纠正解剖异常(导致解剖性干眼),应是任何治疗的主要意图。将概述和讨论细胞应激作为恶性循环关键中心的特征。

相似文献

1
Cellular Stress in Dry Eye Disease-Key Hub of the Vicious Circle.干眼疾病中的细胞应激——恶性循环的关键枢纽
Biology (Basel). 2024 Aug 28;13(9):669. doi: 10.3390/biology13090669.
2
Ocular Surface Allostasis-When Homeostasis Is Lost: Challenging Coping Potential, Stress Tolerance, and Resilience.眼表面稳态失衡——当内稳态丧失时:挑战应对潜能、应激耐受力和弹性。
Biomolecules. 2023 Aug 14;13(8):1246. doi: 10.3390/biom13081246.
3
[A new approach for better comprehension of diseases of the ocular surface].[一种更好理解眼表疾病的新方法]
J Fr Ophtalmol. 2007 Mar;30(3):239-46. doi: 10.1016/s0181-5512(07)89584-2.
4
Expression of GPR-68 in Human Corneal and Conjunctival Epithelium. Possible indicator and mediator of attrition associated inflammation at the ocular surface.GPR-68在人角膜和结膜上皮中的表达。眼表磨损相关炎症的可能指标和介质。
J Fr Ophtalmol. 2023 Jan;46(1):19-24. doi: 10.1016/j.jfo.2022.07.006. Epub 2022 Dec 8.
5
Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification.干眼症治疗:泪液替代物的作用、未来发展及更新分类
Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):8642-8652. doi: 10.26355/eurrev_202009_22801.
6
The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options.干眼疾病的免疫学基础及当前局部治疗选择。
J Ocul Pharmacol Ther. 2020 Apr;36(3):137-146. doi: 10.1089/jop.2019.0060. Epub 2020 Mar 12.
7
Impact of Attrition, Intercellular Shear in Dry Eye Disease: When Cells are Challenged and Neurons are Triggered.眼干燥症中细胞耗竭、细胞间剪切力的影响:当细胞受到挑战和神经元被触发时。
Int J Mol Sci. 2020 Jun 18;21(12):4333. doi: 10.3390/ijms21124333.
8
Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction.重新审视干眼疾病的恶性循环:聚焦睑板腺功能障碍的病理生理学
Br J Ophthalmol. 2016 Mar;100(3):300-6. doi: 10.1136/bjophthalmol-2015-307415. Epub 2016 Jan 18.
9
Management Strategies for Evaporative Dry Eye Disease and Future Perspective.蒸发过强型干眼的管理策略及未来展望。
Curr Eye Res. 2022 Jun;47(6):813-823. doi: 10.1080/02713683.2022.2039205. Epub 2022 May 6.
10
Potential New Target for Dry Eye Disease-Oxidative Stress.干眼症的潜在新靶点——氧化应激
Antioxidants (Basel). 2024 Mar 29;13(4):422. doi: 10.3390/antiox13040422.

引用本文的文献

1
A Potential Role for c-MYC in the Regulation of Meibocyte Cell Stress.c-MYC在睑板细胞应激调节中的潜在作用。
Cells. 2025 May 14;14(10):709. doi: 10.3390/cells14100709.

本文引用的文献

1
Translation regulation in response to stress.应激反应中的翻译调控。
FEBS J. 2024 Dec;291(23):5102-5122. doi: 10.1111/febs.17076. Epub 2024 Feb 3.
2
The inclusion of the epithelium in numerical models of the human cornea.纳入人眼角膜数值模型的上皮细胞。
Biomech Model Mechanobiol. 2024 Jun;23(3):709-720. doi: 10.1007/s10237-023-01801-7. Epub 2023 Dec 21.
3
Effects of cyclosporine on steroid-refractory dry eyes.环孢素对类固醇难治性干眼症的影响。
Taiwan J Ophthalmol. 2023 Mar 24;13(3):306-316. doi: 10.4103/tjo.TJO-D-22-00165. eCollection 2023 Jul-Sep.
4
Oxidative stress in the eye and its role in the pathophysiology of ocular diseases.眼睛中的氧化应激及其在眼部疾病病理生理学中的作用。
Redox Biol. 2023 Dec;68:102967. doi: 10.1016/j.redox.2023.102967. Epub 2023 Nov 18.
5
Cellular Stress: Modulator of Regulated Cell Death.细胞应激:程序性细胞死亡的调节因子
Biology (Basel). 2023 Aug 25;12(9):1172. doi: 10.3390/biology12091172.
6
Ocular Surface Allostasis-When Homeostasis Is Lost: Challenging Coping Potential, Stress Tolerance, and Resilience.眼表面稳态失衡——当内稳态丧失时:挑战应对潜能、应激耐受力和弹性。
Biomolecules. 2023 Aug 14;13(8):1246. doi: 10.3390/biom13081246.
7
The ubiquitin codes in cellular stress responses.泛素码在细胞应激反应中的作用。
Protein Cell. 2024 Feb 29;15(3):157-190. doi: 10.1093/procel/pwad045.
8
Tear biomarkers in dry eye disease: Progress in the last decade.干眼疾病的泪液生物标志物:过去十年的进展。
Indian J Ophthalmol. 2023 Apr;71(4):1190-1202. doi: 10.4103/IJO.IJO_2981_22.
9
Efficacy of Topical Administration of Corticosteroids for the Management of Dry Eye Disease: Systematic Review and Meta-Analysis.局部应用皮质类固醇治疗干眼疾病的疗效:系统评价与荟萃分析
Life (Basel). 2022 Nov 19;12(11):1932. doi: 10.3390/life12111932.
10
A randomized multicenter evaluation of the efficacy of 0.15% hyaluronic acid versus 0.05% cyclosporine A in dry eye syndrome.一项随机多中心评估 0.15%透明质酸与 0.05%环孢素 A 在干眼症综合征中的疗效。
Sci Rep. 2022 Nov 4;12(1):18737. doi: 10.1038/s41598-022-21330-0.